Paper 77 - BIOCHEMICAL PROFILING OF IDRX-42 AND NB003 AGAINST KIT PRIMARY, SECONDARY, AND TERTIARY MUTATIONS

Co-Author(s)

• AT

  Ajia Town, B.S.

  Research Associate
  OHSU Knight Cancer Institute
  Portland, Oregon, United States
• MR

  Marcelina Roberti, B.S.

  OHSU Knight Cancer Institute
  Por, Oregon, United States

Author(s)

• 

  Michael C. Heinrich, MD FACP

  Professor
  Department of Medicine, Oregon Health & Science University
  Portland, Oregon, United States

  Slides

Co-Author(s)

• 

  Sebastian Bauer, MD (he/him/his)

  Director Sarcoma Center at the West German Cancer Center
  Universitaetsklinikum Essen – Westdeutsches Tumorzentrum (WTZ) (West German Cancer Center)
  Essen, Nordrhein-Westfalen, Germany